Sign In
Last checked at 
2 Jun 2026 09:00
2 June 2026
Dr. Martens plc (the "Company")
2026 Annual Report and Notice of Annual General Meeting
Further to the announcement of its preliminary results for the financial period ended 29 March 2026 and in accordance with UK Listing Rules 6.4.1R and 6.4.3R, the Company announces that the following documents have been submitted in unedited full text to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism:
· Annual Report and Accounts for the financial period ended 29 March 2026 (the "2026 Annual Report")
· Notice of the 2026 Annual General Meeting (the "2026 Notice of Meeting"), which will take place at 9.30am on Wednesday 15 July 2026 at 1-11 Hawley Crescent, Camden, London, NW1 8NP
· Proxy form for the 2026 Annual General Meeting
In accordance with rule 6.3.5R of the Disclosure Guidance and Transparency Rules, the 2026 Annual Report and 2026 Notice of Meeting are also available in unedited full text on the Company's website, www.drmartensplc.com.
For further information, please contact:Paul Rolling, Head of Secretariat+447584243562
Bethany Barnes, Director of Investor Relations and Corporate Communications+447825187465
ENDS
About Dr. Martens
Dr. Martens is an iconic British footwear brand founded in Northamptonshire, England. Its first silhouette, the 1460 boot - named after the date it was produced - rolled off the production line on 1st April 1960. Originally chosen by workers for their air-cushioned comfort and durability, "Docs" or "DM's" were later adopted by musicians and subcultural pioneers who took them from the street to the global stage.
Over six decades later, Dr. Martens operates in more than 60 countries and employs around 3,600 people. The company continues to honour the brand's heritage through its 'Made in England' footwear, manufactured at its original Northamptonshire factory, while meeting global demand from multiple high-quality production sites across Asia. All our products are made with an unwavering commitment to craft, combined with innovative techniques.
A brand built to put a bounce in the step of those who stand out from the crowd, Dr. Martens is available through Direct-to-Consumer (Retail and Ecommerce) and Wholesale channels. The brand's collections range from its Original silhouettes - The Icons such as the 1460 boot, 1461 shoe, 2976 Chelsea boot, and Adrian loafer - to modern franchises like the Zebzag, Buzz, and Lowell. The lineup also includes an extensive range of sandals, a dedicated Kids collection, and a curated selection of bags, small leather goods, and accessories.
Every Dr. Martens product reflects craftsmanship, heritage, timeless style, comfort, and versatility. Having transcended generations, the brand stays as relevant today as it was at its inception. Its signature yellow welt stitching, grooved sole edges, and scripted "With Bouncing Soles" heel loops remain iconic symbols recognised around the world.
Dr. Martens plc (DOCS.L) is listed on the main market of the London Stock Exchange and is a constituent of the FTSE 250 index.
For more information, visit www.drmartens.com or www.drmartensplc.com
Follow the stocks
